
بیوتیک
آنتي بيوتيك سازي ايران
تریدر | نوع پیام | حد سود/ضرر | زمان انتشار | مشاهده پیام |
---|---|---|---|---|
MohammadrezamobaseriRank: 613 | خرید | حد سود: ۵۲٬۵۰۰ حد ضرر: ۲۴٬۰۰۰ | 13 hour ago | |
خرید | حد سود: تعیین نشده حد ضرر: تعیین نشده | 9/15/2025 | ||
فروش | حد سود: تعیین نشده حد ضرر: تعیین نشده | 9/29/2025 | ||
خرید | حد سود: تعیین نشده حد ضرر: تعیین نشده | 9/21/2025 | ||
![]() زیبا سرشت - کریم زادهRank: 292 | خرید | حد سود: تعیین نشده حد ضرر: تعیین نشده | 8/18/2025 |
Adjusted Price Chart of بیوتیک
سود 3 Months :
پیامهای بیوتیک
Filter
Sort messages by
Trader Type
Time Frame
Mohammadrezamobaseri

The upward trend is being found Back to the floor purchase up to 5 % portfolio Had a risk to Rivard 1 to 10

سرمایه گذاری برای آینده بهتر
| Hi dear friend We start the market as some technicians believe that the index to cross the level of 2.700,000 needs rest and renewal. "The German Foreign Minister said:" The trigger mechanism was activated soon. "This was the most important news that is apparently the reason for the rise in the dollar. Each 18 -gram of gold is in the 8.780.000 range and the dollar on the eve of 100,000 Among the foods #Ghazar reached 36,000 billion rials in 5 months, up 56% compared to the same period last year but less than July. It has done well #Zakasht has sold 80 billion average monthly and has been stronger than last year, the company has reached a good sales of 320 billion in the first four months of the year, which has increased more than 50% compared to last year! In the 5 -month drug group, the #Dezagress Pharmaceutical Group reached 13748 billion rials and was 2615 billion rials in August, which had a slight retreat to sell 3004 billion rials. It was selling 12004 billion rials in 5 months and it did well compared to the previous performance. In the #Sarum Cement Group, it has sold 18619 billion rials and has done well so far from #Sogdir. This year about 260 USD can make a profit and have a good dividend in the forum. This report is merely a personal analysis and should not be considered a recommendation or sale recommendation. #Disclaimer. 🤷🤷♂

صندوق سرمایه گذاری بخشی صنایع مفید -دارونو
The Investment Fund for useful industries -Darono bought 0.025 million shares of biotics on 24/06/24 and currently holds 1.713 % of biotic shares in its equity portfolio.

بورسی های گیلان
#Medication (2) monthly ❇️ 5 months performance to 5 months 403 (Billion USD) ●#Dajabar income [602 MT] 6% drop ●#Biotics Income [742 MT] Growth 23% Growth ● #Darm Revenue [432 MT] Growth 40% ●#Income Revenue [503 MT] Growth 32% ●#Dekimi Income [394 MT] Growth 48% Growth ●#KBC Revenue [268m] Growth 307% ●#Long revenue [4,980mm] 2% drop ●#Claimer Income [826 MT] Growth 121% ●#Disaster Revenue [963 MT] Growth 42% Growth ●#Dabor Revenue [1,410 MT] Growth 55% ●#Daine of Income [158m] Growth 41% ●#24% Growth Income [484 MT] ●#53% growth in revenue [583 MT] ●#Lolk Income [941m] Growth 67% ●#Deanco Income [249 MT] Growth 9% Growth ●#Delibal Revenue [449 MT] Growth 84% Growth ●#Dasouh Revenue [341m] 12% Growth ●#Druz income [182m] 15% drop ●#Income Income [333m] Growth 71% ●#Di in Revenue [293 MT] Growth 35% Growth
Mohammadrezamobaseri

Biotics Ascending trend Good Foundation Due to the activation of the trigger mechanism and the problems in the pharmaceutical industry and the increase in potential prices was a positive profit process. Be purchased in a few steps

زیبا سرشت - کریم زاده
Buy biotics ....

زیبا سرشت - کریم زاده
I have been discussing biotics in the past few days, which was shown to be a share of the share .... Today is a purchase queue.

زیبا سرشت - کریم زاده
Biotics are more likely to be corrected at these prices than ... with this share more share than the fluctuation .....

زیبا سرشت - کریم زاده
Biotics also reached positive prices at the border of sales. And has a good shock

💰کلوپ مالی بورس 💎
108% of the price growth profit last year was for #biotics @alihadaf_bours Www.alihadaf.com The reversal process and the new structure of the specified areas were formed
Disclaimer
Any content and materials included in Sahmeto's website and official communication channels are a compilation of personal opinions and analyses and are not binding. They do not constitute any recommendation for buying, selling, entering or exiting the stock market and cryptocurrency market. Also, all news and analyses included in the website and channels are merely republished information from official and unofficial domestic and foreign sources, and it is obvious that users of the said content are responsible for following up and ensuring the authenticity and accuracy of the materials. Therefore, while disclaiming responsibility, it is declared that the responsibility for any decision-making, action, and potential profit and loss in the capital market and cryptocurrency market lies with the trader.